Umer Raffat

Stock Analyst at Evercore ISI Group

(0)
# 4080
Out of 5,298 analysts
24
Total ratings
52.94%
Success rate
-11.88%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
MTSR Metsera
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Feb 25, 2025
SYRE Spyre Therapeutics
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 16, 2024
AMLX Amylyx Pharma
Downgrades: In-Line
n/a
n/a n/a 2 Mar 8, 2024
GUTS Fractyl Health
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Feb 28, 2024
RAPT RAPT Therapeutics
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Feb 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jun 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 1 May 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jun 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
48
0.58 8175.86% 1 Mar 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 2 Jan 21, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
1040
n/a n/a 1 Mar 19, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Jan 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
48
7.21 565.74% 1 Jun 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Feb 23, 2017